Jpmorgan Chase & Co »

Turnstone Biologics Corp shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Turnstone Biologics Corp (TSBX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Turnstone Biologics Corp

Tip: Access up to 7 years of quarterly data

All positions including Turnstone Biologics Corp held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Turnstone Biologics Corp by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $16k 6.2k 2.62
2023-12-31 $11k 4.2k 2.55
2023-09-30 $17k 4.2k 3.94

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
SPDR S&P 500 ETF Ser 1 S&P Common (SPY)
Amazon Common (AMZN)
Apple Common (AAPL)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Mastercard Incorporated Common (MA)
Unitedhealth Group Common (UNH)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard index Fds S&P 500 ETF Common (VOO)
Abbvie Common (ABBV)
Exxon Mobil Corp Common (XOM)
Alphabet Common (GOOGL)

View all positions for Jpmorgan Chase & Co

Top funds holding Turnstone Biologics Corp

OrbiMed Advisors
FMR
Point72 Asset Management
Bank of America Corporation
Citadel Advisors
BlackRock
Partner Fund Management
72 Investment Holdings
Eventide Asset Management
ExodusPoint Capital Management
Vanguard Group
Geode Capital Management
Fil
Zimmer Partners
Barclays

View all funds holding Turnstone Biologics Corp